Table: begin end state 1 25 cytoplasmic 26 46 transmembrane 47 65 non-cytoplasmic 66 87 transmembrane 88 98 cytoplasmic 99 119 transmembrane 120 127 non-cytoplasmic 128 152 transmembrane 153 162 cytoplasmic 163 186 transmembrane 187 196 non-cytoplasmic 197 216 transmembrane 217 250 cytoplasmic 251 273 transmembrane 274 288 non-cytoplasmic 289 310 transmembrane 311 316 cytoplasmic 317 334 transmembrane 335 345 non-cytoplasmic 346 369 transmembrane 370 379 cytoplasmic 380 402 transmembrane 403 407 non-cytoplasmic 408 429 transmembrane 430 437 cytoplasmic
Input: >N515DRAFT_1367 FitnessBrowser__Dyella79:N515DRAFT_1367 MTQAAPSVSPLDSSAPRLNRNDLRTLALAALGGALEFYDFVVFVFFTKALGQLFFPADMP EWLAQVQVYGIFAAGYLARPLGGIVMAHFGDRTGRKRMFTLSVFLMALPTLCIGLLPTYA QLGVFAPMLLLLLRVVQGVAIGGEVPGAWVFVAEHAPPGRVGFACASLTSGLTAGILIGS LVAAGVTGMGAEKMLAYGWRLPFILGGVFGFFAVWLRRWLSETPVFAELRERKELASELP LKRVMTGHLGGVLLSMLVTWMLTAAVVVVILMTPTLVQSSFHLPQKLAFHGNSLAALMLC FGCIAGGVAVDRFGRGWSLLVGSVALLVTTYLLYRDLGQGAEHFMLLYALAGLCVGVVGV VPAVMVAAFPPAVRFSGLSFSYNIAYAVFGAITPPLIAYLAAKLGPMAPAHYVAVTAAIG VLCAVYLLTTRREFHER
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server